Sodium 4-methyl-2-oxovalerate
SIGMA/K0629 - leucine metabolite
Synonym: α-Ketoisocaproic acid sodium salt; 4-
CAS Number: 4502-00-5
Empirical Formula (Hill Notation): C6H9NaO3
Molecular Weight: 152.12
EC Number: 224-816-3
MDL Number: MFCD00064193
Linear Formula: (CH3)2CHCH2COCOONa
Product Type: Chemical
| application(s) | cell analysis |
| assay | >98% (TLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C6H10O3.Na/c1-4(2)3-5( |
| InChI key | IXFAZKRLPPMQEO-UHFFFAOYSA |
| mp | 275 °C (dec.) (lit.) |
| Quality Level | 100 ![]() |
| SMILES string | [Na+].CC(C)CC(=O)C([O-])= |
| storage temp. | 2-8°C |
| technique(s) | HPLC: suitable |
| Application: | Sodium 4-methyl-2-oxovalerate has been used for quantifying branched-chain keto acids from cell extracts by HPLC-fluorescence method. |
| Biochem/physiol Actions: | α-Ketoisocaproic acid is a leucine metabolite that is known to induce insulin secretion from the βcells of pancreas. Enteral infusion of aα-Ketoisocaproate is found to ameliorate, endotoxemic condition. The resulting ketone bodies obtained from its conversion, might serve as an energy source. Accumulation of α-Ketoisocaproic acid is characterized in branched chain ketoaciduria, which is caused due to the lack of branched chain L-2-keto acid dehydrogenase activity. α-Ketoisocaproic acid causes dissociation in the oxidative phosphorylation reaction and acts as a metabolic inhibitor of α-ketoglutarate dehydrogenase. Thus, leads to a defect in the mitochondrial homeostasis, observed in branched chain ketoaciduria. |
| Packaging: | 1, 5 g in poly bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | >98% (TLC) |
| mp | 275 °C (dec.) (lit.) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352107 |

